Interactions between lorcaserin and opioids: Ventilation and food-versus-drug choice
Pharmacology Biochemistry and Behavior · 2024-01 · 234 · 173673
DOI: 10.1016/j.pbb.2023.173673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2024-01. Verfasst von David R Maguire. Beteiligte Einrichtung: Department of Pharmacology and Addiction Research, Treatment & Training Center of Excellence, University of Texas Health Science Center at San Antoni…. Hauptthemen laut MEDLINE: Analgesics, Opioid, Respiratory Insufficiency. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Lorcaserin, a selective serotonin 2C (5-HT2C) receptor agonist, was approved for treating obesity and has been investigated for treating substance use disorders including those involving opioids. Although lorcaserin was withdrawn from the market, interest in the therapeutic potential of drugs acting at 5-HT2C receptors continues, supporting the need to further characterize potential adverse effects especially when combined with drugs of abuse. This study examined acute effects of lorcaserin on opioid-induced ventilatory depression, which is the primary cause of overdose, and opioid self-administration, which models factors contributing to opioid abuse, in male and female rhesus monkeys. In one group (n = 4), effects of morphine (0.178 to 5.6 mg/kg, s.c.), fentanyl (0.0032 to 0.1 mg/kg, s.c.), and lorcaserin (0.1 to 1.78 mg/kg, s.c.) alone as well as effects of lorcaserin with each opioid on ventilation were determined using head plethysmography. Another group (n = 5) responded under a food versus fentanyl (0.1 to 3.2 μg/kg/infusion, i.v.) choice procedure, and lorcaserin (0.32 to 1.78 mg/kg, i.v.) was given as a pretreatment. Lorcaserin dose-dependently decreased minute volume to below 70 % of baseline when administered alone and increased the potency of morphine and fentanyl. Consistent with previous studies, lorcaserin failed to alter choice of fentanyl over food. This study demonstrates the novel finding that lorcaserin alone decreases ventilation and enhances the ventilatory-depressant effects of opioids. Taken together with previous studies, these results suggest that combining a 5-HT2C receptor agonist such as lorcaserin with an opioid could increase the risk of ventilatory depression without the benefit of decreasing abuse.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Addiction Research, Treatment & Training Center of Excellence, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78229, USA. Electronic address…
Förderung
- NIDA NIH HHS
- National Institutes of Health
Zitieren
APA
Maguire, D. R. (2024). Interactions between lorcaserin and opioids: Ventilation and food-versus-drug choice. Pharmacology Biochemistry and Behavior, 234, 173673. https://doi.org/10.1016/j.pbb.2023.173673
Vancouver
Maguire DR. Interactions between lorcaserin and opioids: Ventilation and food-versus-drug choice. Pharmacology Biochemistry and Behavior. 2024;234:173673. doi:10.1016/j.pbb.2023.173673
BibTeX
@article{Maguire2024,
author = {Maguire, David R},
title = {Interactions between lorcaserin and opioids: Ventilation and food-versus-drug choice},
journal = {Pharmacology Biochemistry and Behavior},
year = {2024},
volume = {234},
pages = {173673},
doi = {10.1016/j.pbb.2023.173673}
}
EUVIMED